Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer.

Li, Lingfei; Li, Mingyang; Jia, Qingge

Li, Lingfei; Li, Mingyang; Jia, Qingge.

Affiliation

Li L; State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
Li M; State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China. Electronic address: limingyang1108@sina.com.
Jia Q; Department of Reproductive Medicine, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China. Electronic address: 361400283@qq.com.

Pathol Res Pract ; 248: 154711, 2023 Aug.

Article in En | MEDLINE | ID: mdl-37494802

Subject(s)

Myeloid-Derived Suppressor Cells; Neoplasms; Humans; Myeloid-Derived Suppressor Cells/metabolism; Myeloid-Derived Suppressor Cells/pathology; Neoplasms/pathology; Immunotherapy; T-Lymphocytes, Regulatory; Tumor Microenvironment

Key words

Cancer; Immunotherapy; Myeloid-derived suppressor cell; Tumor microenvironment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myeloid-Derived Suppressor Cells / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pathol Res Pract Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google